BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1475 related articles for article (PubMed ID: 8649813)

  • 21. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.
    Takayama S; Krajewski S; Krajewska M; Kitada S; Zapata JM; Kochel K; Knee D; Scudiero D; Tudor G; Miller GJ; Miyashita T; Yamada M; Reed JC
    Cancer Res; 1998 Jul; 58(14):3116-31. PubMed ID: 9679980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation.
    Janji B; Melchior C; Vallar L; Kieffer N
    Oncogene; 2000 Jun; 19(27):3069-77. PubMed ID: 10871859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS.
    Schwarz MJ; Müller N; Körschenhausen D; Kirsch KH; Penning R; Ackenheil M; Johnson JP; Hampel H
    Neuroimmunomodulation; 1998; 5(5):270-6. PubMed ID: 9730695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mader.
    Edinb Med J; 1878 Jan; 23(7):667. PubMed ID: 29639816
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
    Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
    Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
    Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
    J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor antigens and tumor vaccines: peptides as immunogens.
    Slingluff CL
    Semin Surg Oncol; 1996; 12(6):446-53. PubMed ID: 8914209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose adjuvant interferon therapy for melanoma.
    Licata AG
    Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sun Smart Day: a pilot program for photoprotection education.
    Buller MK; Goldberg G; Buller DB
    Pediatr Dermatol; 1997; 14(4):257-63. PubMed ID: 9263304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined surgery and cryotherapy for melanoma of the conjunctiva: 37 months' follow-up.
    Cagini C; Menduno P; Ignagni S
    Eur J Ophthalmol; 1996; 6(3):343-5. PubMed ID: 8908446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects.
    Spatz A; Ruiter D; Hardmeier T; Renard N; Wechsler J; Bailly C; Avril MF; Kwee H; Bastian BC; Hill C; De Potter C; Prade M
    Int J Cancer; 1996 Nov; 68(3):317-24. PubMed ID: 8903473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automatic multiparameter fluorescence imaging for determining lymphocyte phenotype and activation status in melanoma tissue sections.
    Dow AI; Shafer SA; Kirkwood JM; Mascari RA; Waggoner AS
    Cytometry; 1996 Sep; 25(1):71-81. PubMed ID: 8875056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological aspects of melanomas [proceedings].
    The TH; de Gast GC; Huiges HA; Schraffordt Koops H
    Ophthalmologica; 1977; 175(1):25-7. PubMed ID: 904885
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein.
    Matsui T; Kageshita T; Ishihara T; Tomiguchi S; Takahashi M; Ono T
    Dermatology; 1998; 197(1):65-8. PubMed ID: 9693191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.
    Bajetta E; Rimassa L; Carnaghi C; Del Vecchio M; Celio L; Cassata A
    Tumori; 1998; 84(1):48-51. PubMed ID: 9619714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice.
    Iakoubov LZ; Torchilin VP
    Oncol Res; 1997; 9(8):439-46. PubMed ID: 9436197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants.
    Carpenter LM; Swerdlow AJ; Fear NT
    Occup Environ Med; 1997 Jun; 54(6):388-95. PubMed ID: 9245944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giant congenital nevocellular nevus overlying an encephalocele.
    Shermak MA; Perlman EJ; Carson BS; Dufresne CR
    J Craniofac Surg; 1996 Sep; 7(5):376-83. PubMed ID: 9133851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.